Structural studies of the capsular polysaccharide of a non-neoformans Cryptococcus species identified as C. laurentii, which was reclassified as Cryptococcus flavescens, from a patient with AIDS.
Cryptococcus flavescens, a strain originally identified as C. laurentii, was isolated from the cerebrospinal fluid of an AIDS patient, and the soluble capsular polysaccharide of the yeast was investigated. Glucuronoxylomannan (GXM) was obtained from C. flavescens under conditions similar to those used to obtain C. neoformans polysaccharide. However, the GXM differed from C. neoformans polysaccharide in the decreased O-acetyl group content. The structure of GXM was determined by methylation analysis, partial acid hydrolysis, NMR analyses, and controlled Smith degradation. These analyses indicated that GXM has the following structure: an alpha-(1-->3)-D-mannan backbone with side chains of beta-D-glucuronic acid residues bound to the C-2 position of the mannose residue. The C-6 position of the mannose is substituted with D-man-beta-(1-->4)-D-xyl-beta-(1--> disaccharide. Furthermore, the existence of side chains containing more than two xylose residues was suggested. This mannosylxylose side chain is a novel structure in polysaccharides of C. neoformans and other Cryptococcus species.
Ikeda
Reiko
R
Department of Microbiology, Meiji Pharmaceutical University, 2-522-1, Noshio, Kiyose, Tokyo 204-8588, Japan. ikeda@my-pharm.ac.jp
Maeda
Takumi
T
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000382:microbiology*; D003453:Cryptococcosis / Q000150:complications* / Q000382:microbiology; D003454:Cryptococcus / Q000737:chemistry* / Q000145:classification* / Q000302:isolation & purification; D003455:Cryptococcus neoformans; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008745:Methylation; D011134:Polysaccharides / Q000032:analysis* / Q000737:chemistry*
D011134:Polysaccharides; C027478:glucuronoxylomannan